月相影响睡眠的具体神经内分泌通路

Written by

in

Language

Evidence level: B

月相对睡眠的影响,最可能落在”光照-视交叉上核-松果体-褪黑素-褪黑素受体”这条神经内分泌通路上,且个体差异由褪黑素受体基因(MTNR1A/MTNR1B)的多态性部分决定

正文(1000-1500字)

“满月之夜睡不安稳”是横跨东西方的古老直觉。上一篇文章《月相与睡眠结构》已经确立了现象层的事实:月相确实能在多导睡眠图中留下可测量的印记。但现象背后的具体通路是什么?月光的信号是如何一步步从视网膜传导到松果体、再改变化学递质浓度、最终扰动睡眠结构的?

要回答这个问题,必须沿着人体现成的神经内分泌线路图来找。这条线路图以视交叉上核(SCN,下丘脑的昼夜节律主时钟)为核心:视网膜上的光敏神经节细胞通过视网膜-下丘脑束把光照信息送入 SCN,SCN 再经由室旁核、中间外侧柱、颈上神经节的复杂多突触通路,把”天黑了”的信号传递给松果体,后者据此合成并分泌褪黑素(melatonin)。褪黑素浓度在夜间达到峰值、白天被 460-480 纳米的蓝光抑制——这套”光照-SCN-松果体-褪黑素”轴,就是人体把外界光环境翻译成内分泌指令的骨干管道(PMID 27314810)。

月相研究最关键的贡献,正在于把这条轴与 29.5 天的朔望周期对接起来。瑞士巴塞尔大学 Cajochen 团队在完全受控的暗室研究中发现:满月前后,NREM 睡眠的 EEG delta 活动(深睡眠指标)下降约 30%,入睡潜伏期延长约 5 分钟,总睡眠时间减少约 20 分钟,且伴随内源褪黑素水平降低——注意,受试者全程身处无时间线索的实验室,月光从未直接照射到他们,因此这一结果很难用”满月更亮让人睡不着”解释,反而指向一个内源性的、近月周期的振荡(PMID 23891110)。2023 年一项儿童研究进一步把这条通路下探到低龄人群:3-6 岁儿童在严格昏暗环境(<10 勒克斯)下采集唾液褪黑素,满月附近多个采样时点的褪黑素浓度显著低于新月附近(睡前 20 分钟:满月 15.5 vs 新月 26.1 pg/ml;睡前 50 分钟:19.9 vs 34.3 pg/ml),说明”褪黑素随月相波动”并非成人独有,而是从发育早期就存在的内源节律(PMID 35567349)。

那么,褪黑素水平的月相波动,如何转化为睡眠结构的个体差异?答案藏在信号接收端——褪黑素受体。人类有两个褪黑素受体基因:MTNR1A 编码 MT1 受体、MTNR1B 编码 MT2 受体,两者都分布在视交叉上核、皮层、海马、丘脑等与睡眠和昼夜节律直接相关的脑区,激活后经 Gαi 通路抑制 cAMP-PKA 信号、并调节 ERK1/2 通路(PMID 27314810)。IUPHAR 综述指出:MTNR1A 上的功能性变异(如 R54W、A157V)在非 24 小时睡眠-觉醒综合征患者中出现频率升高——也就是说,同样的褪黑素节律信号,会因为受体基因型不同而在不同人身上产生强弱不一的睡眠反应(PMID 27314810)。这正是”月相对睡眠的影响因人而异”的分子层面解释:月相把褪黑素这剂”安眠药”的浓度上下拨动,而每个人能”接住”多少药效,由他的受体基因型决定。

但必须诚实面对反方证据。洛桑大学一项 2125 人的大样本家测 PSG 研究(含 759 人 EEG 频谱分析)未发现月相与主观睡眠质量、客观睡眠时长、EEG 参数或日间皮质醇有任何显著关联(PMID 26498230)。Cordi 等人对三大睡眠数据集的再分析也未能复现满月效应,并指出阳性结果可能被”文件抽屉效应”(阴性结果不发表)放大。综合来看,月相-睡眠关联的真实效应量很可能很小(儿童研究约 5 分钟级),在个体层面几乎无临床意义,但在群体统计层面确实存在,且方向一致(满月附近睡眠更浅、更短)。

把这条通路放回中医”天人相应”的框架里看:褪黑素正是人体把”天时(光照周期)”翻译成”体内状态(睡眠-觉醒、免疫、代谢)”的分子使者,而朔望月的月光亮度变化构成了一个天然的、缓慢的次级节律输入。现代研究尚未在人体找到独立的”近月钟”基因,但”SCN-松果体-褪黑素-受体基因型”这条轴已经为古老的月相直觉提供了具体的、可检验的神经内分泌通路假说。

证据与局限

已验证: 满月附近内源褪黑素水平降低(受控实验室+儿童唾液样本,PMID 23891110、35567349);满月附近深睡眠 EEG delta 活动下降、入睡变慢(PMID 23891110);褪黑素受体 MTNR1A/MTNR1B 功能性变异存在且部分与睡眠/昼夜节律疾病相关(PMID 27314810)。

部分验证: 褪黑素波动”如何”经由受体基因型转化为睡眠个体差异,仅有间接证据(受体变异在昼夜节律疾病中富集,但未在健康人群的月相-睡眠研究中直接测序验证);儿童研究样本量小(n=46)。

待验证: ① 在健康人群中同时采集月相、唾液褪黑素与 MTNR1A/MTNR1B 基因分型,检验”基因型×月相”对睡眠结构的交互作用;② 是否存在独立于光照的人体内源近月振荡器(可在持续昏暗/恒暗环境中做纵向监测);③ 人工光照(蓝光污染)如何压制或重塑这条月相通路。

相关阅读

证据等级: B(月相-褪黑素关联有PubMed直接支撑,受体基因型→睡眠个体差异的通路属间接证据)
参考文献: PMID 23891110, PMID 35567349, PMID 27314810, PMID 26498230


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Specific Neuroendocrine Pathways by Which Lunar Phases Affect Sleep

Evidence level: B

The influence of the lunar phase on sleep most likely operates via the “light-retinal hypothalamic pineal-melatonin-melatonin receptor” neuroendocrine pathway, with individual differences partially determined by polymorphisms in melatonin receptor genes (MTNR1A/MTNR1B).

Main Text (1000-1500 words)

The intuition that “full moons disrupt sleep” is an ancient cross-cultural heuristic. The previous article, Lunar Phase and Sleep Structure, established factual findings at the phenomenological level: lunar phases indeed leave measurable imprints on polysomnography. However, what is the specific pathway? How does the signal from moonlight propagate step-by-step from the retina to the pineal gland, alter neurotransmitter concentrations, and ultimately disturb sleep architecture?

To answer this, one must trace the embodied neuroendocrine circuit map of the human body. This map centers on the suprachiasmatic nucleus (SCN), the master circadian clock of the hypothalamus: photoreceptive retinal ganglion cells transmit light information via the retino-hypothalamic tract to the SCN. The SCN then relays the “night has fallen” signal to the pineal gland through a complex polysynaptic pathway involving the paraventricular nucleus, the lateral hypothalamus, and the superior cervical ganglion. The pineal gland subsequently synthesizes and secretes melatonin based on this input. Melatonin concentrations peak at night and are suppressed by blue light in the 460–480 nm range—this “light-SCN-pineal-melatonin” axis constitutes the primary pipeline translating external light environments into endocrine commands (PMID 27314810).

The most significant contribution of lunar phase research lies in docking this axis with the 29.5-day synodic cycle. A team at the University of Basel, led by Cajochen, conducted controlled studies in completely darkened rooms and found that around the full moon, NREM sleep EEG delta activity (a deep sleep indicator) decreased by approximately 30%, sleep onset latency increased by about 5 minutes, total sleep time reduced by roughly 20 minutes, and endogenous melatonin levels were lower—note that subjects remained in a laboratory devoid of temporal cues, and moonlight never directly illuminated them; thus, this result is difficult to explain by “full moons being brighter,” instead pointing toward an endogenous oscillation with a near-lunar periodicity (PMID 23891110). A 2023 pediatric study further probed this pathway in younger populations: children aged 3–6 collected salivary melatonin under strictly dim lighting (<10 lux). Melatonin concentrations at multiple sampling points near the full moon were significantly lower than those near the new moon (20 minutes before bed: Full Moon 15.5 vs. New Moon 26.1 pg/ml; 50 minutes before bed: 19.9 vs. 34.3 pg/ml), indicating that “melatonin fluctuation with lunar phase” is not unique to adults but represents an endogenous rhythm present from early development (PMID 35567349).

So, how does the lunar-phase fluctuation in melatonin levels translate into individual differences in sleep structure? The answer lies at the signal reception end—the melatonin receptor. Humans possess two melatonin receptor genes: MTNR1A encodes the MT1 receptor, and MTNR1B encodes the MT2 receptor. Both are distributed in brain regions directly related to sleep and circadian rhythms, including the SCN, cortex, hippocampus, and thalamus. Upon activation, they inhibit cAMP-PKA signaling via the Gαi pathway and regulate ERK1/2 pathways (PMID 27314810). An IUPHAR review indicates that functional variants on MTNR1A (such as R54W, A157V) occur with higher frequency in patients with non-24-hour sleep-wake disorders—meaning that the same melatonin rhythmic signal produces varying degrees of sleep response across individuals depending on their receptor genotype (PMID 27314810). This provides the molecular-level explanation for “individual differences in sleep response to lunar phase”: the lunar phase adjusts the concentration of this “sleep aid,” while the amount of efficacy each person can “capture” is determined by their receptor genotype.

However, one must honestly confront counter-evidence. A large-scale home-based PSG study of 2,125 individuals from the University of Lausanne (including EEG spectral analysis for 759 participants) found no significant associations between lunar phase and subjective sleep quality, objective sleep duration, EEG parameters, or daytime cortisol levels (PMID 26498230). A reanalysis by Cordi et al. of three major sleep datasets also failed to replicate the full moon effect, suggesting that positive results may be inflated by the “file drawer effect” (non-publication of negative results). Overall, the true effect size of the lunar-sleep association is likely small (on the order of ~5 minutes in children) and has little clinical significance at the individual level, yet it does exist at the group statistical level with a consistent direction (shallower and shorter sleep near the full moon).

Viewing this pathway within the Traditional Chinese Medicine framework of “Man and Nature Correspondence”: melatonin acts as the molecular messenger translating “heavenly time (light cycles)” into “internal states (sleep-wake, immunity, metabolism),” while the brightness variation of moonlight during the synodic month constitutes a natural, slow secondary rhythmic input. Modern research has not yet identified an independent “near-lunar clock” gene in humans, but the axis of “SCN-pineal-melatonin-receptor genotype” already provides a specific, testable neuroendocrine pathway hypothesis for the ancient intuition regarding lunar phases.

Evidence and Limitations

Verified: Reduced endogenous melatonin levels near the full moon (controlled lab + pediatric saliva samples, PMID 23891110, 35567349); decreased deep sleep EEG delta activity and slower sleep onset near the full moon (PMID 23891110); existence of functional variants in melatonin receptors MTNR1A/MTNR1B with partial association to sleep/circadian disorders (PMID 27314810).

Partially Verified: The mechanism by which melatonin fluctuations translate into individual sleep differences via receptor genotype relies on indirect evidence (variants enriched in circadian disorders, but not directly sequenced/verified in healthy populations regarding lunar-sleep studies); pediatric study sample size is small (n=46).

To Be Verified: ① Simultaneous collection of lunar phase, salivary melatonin, and MTNR1A/MTNR1B genotyping in healthy populations to test the interaction effect of “genotype × lunar phase” on sleep structure; ② Existence of an endogenous near-lunar oscillator independent of light exposure (can be monitored longitudinally in sustained dimness/constant darkness); ③ How artificial light pollution (blue light) suppresses or reshapes this lunar pathway.

Related Reading

Evidence Level: B (Direct PubMed support exists for the lunar-melatonin association; the pathway from receptor genotype to individual sleep differences constitutes indirect evidence)
References: PMID 23891110, PMID 35567349, PMID 27314810, PMID 26498230


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *